HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert J Lewandowski Selected Research

Yttrium

10/2021Evolution of Radioembolization in Treatment of Hepatocellular Carcinoma: A Pictorial Review.
1/2021Liver Transplantation Following Yttrium-90 Radioembolization: 15-Year Experience in 207-Patient Cohort.
8/2015Can volumetric ADC measurement help predict response to Y90 radioembolization in HCC?
11/2014Transarterial chemoembolization and yittrium-90 for liver cancer and other lesions.
3/2014Localized hyperthermia with iron oxide-doped yttrium microparticles: steps toward image-guided thermoradiotherapy in liver cancer.
8/2013Prospective evaluation of patients with early-/intermediate-stage hepatocellular carcinoma with disease progression following arterial locoregional therapy: candidacy for systemic treatment or clinical trials.
1/2013Yttrium 90 microspheres for the treatment of hepatocellular carcinoma.
6/2011Transcatheter intraarterial therapies: rationale and overview.
5/2008Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival.
1/2008Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert J Lewandowski Research Topics

Disease

104Neoplasms (Cancer)
08/2022 - 07/2005
70Hepatocellular Carcinoma (Hepatoma)
01/2022 - 08/2005
33Neoplasm Metastasis (Metastasis)
01/2022 - 08/2005
14Liver Neoplasms (Liver Cancer)
11/2021 - 07/2006
9Necrosis
01/2021 - 03/2010
8Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 12/2005
8Thrombosis (Thrombus)
03/2020 - 01/2008
5Ascites
01/2018 - 12/2005
5Fibrosis (Cirrhosis)
12/2017 - 01/2008
5Breast Neoplasms (Breast Cancer)
06/2017 - 05/2007
4Cholangiocarcinoma
08/2022 - 10/2008
4Pathologic Constriction (Stenosis)
12/2020 - 06/2011
4Nausea
07/2017 - 01/2010
4Abdominal Pain (Pain, Abdominal)
07/2012 - 02/2011
3Liver Diseases (Liver Disease)
01/2022 - 12/2005
3Hypertrophy
10/2021 - 11/2018
3Radiation Pneumonitis
07/2021 - 10/2008
3Disease Progression
01/2019 - 05/2007
3Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2017 - 06/2008
3Fatigue
07/2012 - 01/2010
2Infections
03/2020 - 01/2019
2Sarcoma (Soft Tissue Sarcoma)
01/2018 - 06/2017
2End Stage Liver Disease
12/2017 - 12/2006
2Venous Thromboembolism
10/2017 - 12/2015
2Pleural Effusion (Pleural Effusions)
07/2017 - 12/2005
2Cholecystitis
07/2017 - 06/2011
2Liver Failure
07/2017 - 12/2005
2Melanoma (Melanoma, Malignant)
06/2017 - 06/2014
2Venous Thrombosis (Deep-Vein Thrombosis)
07/2014 - 01/2013
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2014 - 08/2009
2Vomiting
07/2012 - 01/2010
1Radiation Injuries (Radiation Sickness)
10/2021
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
08/2021
1Acute Cholecystitis
12/2020
1Hepatitis B
03/2020
1Hemorrhage
01/2020
1Inflammation (Inflammations)
01/2019
1Infarction (Infarctions)
01/2019
1Edema (Dropsy)
01/2019
1Brain Diseases (Brain Disorder)
12/2017
1Wounds and Injuries (Trauma)
10/2017

Drug/Important Bio-Agent (IBA)

67Yttrium-90IBA
08/2022 - 08/2005
14YttriumIBA
10/2021 - 08/2005
13AlbuminsIBA
07/2021 - 01/2010
11BilirubinIBA
06/2019 - 05/2007
8alpha-Fetoproteins (alpha-Fetoprotein)IBA
05/2020 - 12/2009
6Sorafenib (BAY 43-9006)FDA Link
01/2021 - 11/2013
5Pharmaceutical PreparationsIBA
05/2018 - 06/2011
5ferric oxide (iron oxide)IBA
08/2014 - 09/2013
4Indicators and Reagents (Reagents)IBA
02/2018 - 12/2009
3Eosine Yellowish-(YS) (Eosin)IBA
01/2021 - 01/2014
3Hematoxylin (Haematoxylon)IBA
01/2021 - 01/2014
3Biomarkers (Surrogate Marker)IBA
01/2021 - 08/2014
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2018 - 08/2005
3salicylhydroxamic acid (SHAM)IBA
06/2014 - 09/2011
3IronIBA
03/2014 - 12/2008
2Alkaline PhosphataseIBA
12/2020 - 07/2014
2Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2019 - 05/2018
2thiamine triphosphorate (TTP)IBA
09/2016 - 06/2010
2Biological ProductsIBA
05/2016 - 05/2008
2Radioisotopes (Radionuclides)IBA
03/2016 - 06/2011
2Polyglactin 910IBA
08/2015 - 06/2014
1Serum AlbuminIBA
08/2022
1Estradiol (Delestrogen)FDA LinkGeneric
08/2021
1duramycinIBA
04/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
04/2021
1Irinotecan (Camptosar)FDA LinkGeneric
01/2019
1indolepropanol phosphate (IPP)IBA
01/2019
1Ethiodized Oil (Ethiodol)FDA Link
05/2018
1EmulsionsIBA
05/2018
1FluorineIBA
01/2018
1Caspase 3 (Caspase-3)IBA
01/2018
1Immune Checkpoint InhibitorsIBA
11/2017

Therapy/Procedure

66Therapeutics
01/2022 - 07/2005
45Microspheres (Microsphere)
01/2022 - 12/2005
12Drug Therapy (Chemotherapy)
08/2022 - 12/2005
10Segmental Mastectomy (Lumpectomy)
01/2022 - 01/2011
8Liver Transplantation
10/2021 - 12/2006
8Aftercare (After-Treatment)
10/2018 - 08/2005
7Radiofrequency Ablation
01/2022 - 12/2006
7Catheters
02/2012 - 08/2005
6Transplantation
12/2017 - 12/2006
5Surgical Portasystemic Shunt (Portosystemic Shunt)
01/2021 - 01/2013
4Transjugular Intrahepatic Portasystemic Shunt
01/2021 - 01/2013
4Radiotherapy
12/2015 - 01/2008
3Contraindications
01/2020 - 11/2015
3Electrodes (Electrode)
01/2018 - 02/2012
3Therapeutic Embolization
09/2015 - 03/2007
3Palliative Care (Palliative Therapy)
06/2014 - 01/2013
3Combination Drug Therapy (Combination Chemotherapy)
05/2007 - 08/2005
2Ablation Techniques
01/2022 - 09/2016
2Cryosurgery
01/2022 - 09/2016
2Neoadjuvant Therapy
01/2021 - 05/2019
2Immunotherapy
07/2019 - 11/2017
2Vena Cava Filters (Inferior Vena Cava Filter)
03/2019 - 06/2016
2Brachytherapy
03/2014 - 05/2007
1Injections
01/2020
1Lasers (Laser)
01/2020
1Stents
03/2019
1Thrombectomy
03/2019